Market revenue in 2023 | USD 1,171.8 million |
Market revenue in 2030 | USD 2,807.6 million |
Growth rate | 13.3% (CAGR from 2023 to 2030) |
Largest segment | Spinal cord stimulator |
Fastest growing segment | Gastric Electric Stimulator |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Spinal Cord Stimulator, Deep Brain Stimulator, Sacral Nerve Stimulator, Vagus Nerve Stimulator, Gastric Electric Stimulator |
Key market players worldwide | Medtronic PLC, LivaNova PLC, Boston Scientific Corp, St. Jude Medical, Nevro Corp |
Spinal cord stimulator was the largest segment with a revenue share of 50.73% in 2023. Horizon Databook has segmented the Europe neurostimulation devices market based on spinal cord stimulator, deep brain stimulator, sacral nerve stimulator, vagus nerve stimulator, gastric electric stimulator covering the revenue growth of each sub-segment from 2018 to 2030.
Europe is one of the most advanced regions globally with advanced technologies and infrastructure resulting in better healthcare facilities and patient care. Increasing incidence of Parkinson’s disease, epilepsy, and demand for minimally invasive procedures can be attributed to the neurostimulation market growth. In addition, increase in investments by government and third parties is also driving the market. However, lack of favorable reimbursement policies is likely to restrain the market growth.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account